Please provide your email address to receive an email when new articles are posted on . Patients discharged without clinical evidence of poor kidney function had an 18% higher mortality risk. Moreover ...
-Data support plans to initiate a Phase 3 study of ivacaftor in people with CF who have a residual function mutation- BOSTON--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the ...
Cannabis is the most widely used illicit drug in the world (UNODC, 2010). Globally, an estimated 147 million adults use illicit marijuana at least once annually, including 30 million Americans (SAMHSA ...
TB006 treatment was well-tolerated with only minor adverse events (AEs), no treatment related serious adverse events (SAEs), and no imaging-related abnormalities FOSTER CITY, Calif., Nov. 18, 2022 ...